Philadelphia and the greater Mid-Atlantic corridor are brimming with scientific talent and breakthrough innovations—yet remain underinvested. BioAdvance Capital is working to change that. In 2024, we doubled down on our mission, backing nine cutting-edge companies pushing the boundaries of gene therapy, AI-driven drug discovery, and precision medicine in this fertile region. From vision-restoring biologics to AI-powered drug design, our portfolio companies are tackling some of the biggest challenges in healthcare. And we’re not just writing checks—we’re hands-on partners, providing the strategic guidance and industry expertise needed to turn bold ideas into life-changing therapies. We’re proud to support the next generation of biotech pioneers in Philadelphia and the mid-Atlantic corridor. The future of healthcare starts here. ?? www.bioadvance.com #LifeSciences #Biotech #Innovation #Philadelphia #Healthcare
关于我们
We invest in early stage life science technology companies with the potential to enhance well-being and quality of life.
- 网站
-
https://bioadvance.com
BioAdvance Capital的外部链接
- 所属行业
- 风险投资与私募股权管理人
- 规模
- 2-10 人
- 总部
- Conshohocken，Pennsylvania
- 类型
- 私人持股
- 创立
- 2003
地点
-
主要
获取路线
101 W Elm St
Ste 330
US，Pennsylvania，Conshohocken，19428